Read + Share
Amedeo Smart
Independent Medical Education
Sehrawat O, Swain WH, Siontis KC. In Response to: Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis. J Cardiovasc Electrophysiol 2024 Dec 30. doi: 10.1111/jce.16532.PMID: 39739448
Email
LinkedIn
Privacy Policy